US Stock MarketDetailed Quotes

TGTX TG Therapeutics

Watchlist

35.000
+0.740+2.16%

Close Nov 27 16:00 ET

35.280
+0.280+0.80%

Post 18:46 ET

5.45BMarket Cap-350000P/E (TTM)

TG Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q3)Sep 30, 2024

(Q2)Jun 30, 2024

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

Operating Cash Flow (Indirect Method)

Cash flow from continuing operating activities

-114.58%-12.21M

113.18%5.54M

86.30%-8.21M

82.17%-31.41M

44.66%-13.21M

342.66%83.7M

14.48%-42.01M

12.79%-59.9M

40.41%-176.17M

72.53%-23.87M

Net income from continuing operations

-96.59%3.88M

114.45%6.88M

72.71%-10.71M

106.39%12.67M

72.80%-14.42M

418.08%113.93M

-17.52%-47.61M

43.15%-39.23M

43.02%-198.34M

43.22%-52.99M

Depreciation and amortization

-49.21%64K

-15.29%72K

-32.23%82K

-17.86%423K

-27.78%91K

-2.33%126K

-35.11%85K

-6.20%121K

4.25%515K

-5.26%126K

Other non cash items

31.39%1.04M

-10.75%1.2M

0.00%1.01M

0.25%4.45M

19.80%1.31M

-53.17%790K

93.08%1.34M

4.66%1.01M

85.28%4.44M

83.58%1.1M

Change In working capital

20.65%-31.83M

-30.44%-10.67M

78.58%-6.07M

-5,040.19%-84.66M

-147.33%-8.05M

-447.47%-40.11M

2.85%-8.18M

-871.66%-28.32M

86.52%-1.65M

294.33%17.01M

-Change in receivables

-47.09%-32.12M

-110.20%-18.63M

-61.07%-13.89M

-3,778.40%-51.09M

---11.77M

-24,913.64%-21.84M

-1,188.57%-8.86M

-1,870.64%-8.62M

200.00%1.39M

--0

-Change in inventory

-0.16%-2.54M

-29.82%-2.56M

-37.17%-36.93M

---36.94M

---5.51M

---2.54M

---1.97M

---26.92M

--0

-Change in payables and accrued expense

154.25%11.67M

-3.44%8.96M

308.01%40.22M

101.74%192K

-84.39%2.56M

-253.69%-21.51M

182.95%9.28M

196.93%9.86M

-168.85%-11.01M

321.07%16.43M

-Change in other current assets

-2,339.18%-25.59M

115.69%1.05M

156.81%1.49M

-134.60%-2.83M

2,122.42%7.53M

-394.81%-1.05M

-616.83%-6.69M

-138.81%-2.62M

196.16%8.18M

127.06%339K

-Change in other current liabilities

-1,388.89%-1.39M

-87.27%14K

9,280.77%2.44M

645.45%300K

-80.21%56K

109.97%108K

-84.24%110K

-44.68%26K

99.70%-55K

102.49%283K

-Change in other working capital

170.28%18.14M

1,410.53%498K

1,684.21%602K

3,857.24%5.71M

-2,336.84%-926K

17,765.79%6.71M

0.00%-38K

0.00%-152K

0.00%-38K

Cash from discontinued investing activities

Operating cash flow

-114.58%-12.21M

113.18%5.54M

86.30%-8.21M

82.17%-31.41M

44.66%-13.21M

342.66%83.7M

14.48%-42.01M

12.79%-59.9M

40.41%-176.17M

72.53%-23.87M

Investing cash flow

Cash flow from continuing investing activities

69.12%-9.33M

-94.21%1.77M

-50.05%-9.26M

-153.09%-50.65M

-375.09%-44.76M

-911.00%-30.23M

193.87%30.5M

85.88%-6.17M

-5,928.01%-20.01M

394.80%16.27M

Net PPE purchase and sale

----

--0

----

96.51%-14K

96.25%-3K

Net investment purchase and sale

69.20%-9.31M

-94.21%1.77M

-50.05%-9.26M

-153.27%-50.65M

-375.04%-44.76M

-912.36%-30.23M

193.87%30.5M

85.87%-6.17M

-29,084.06%-20M

383.14%16.27M

Cash from discontinued investing activities

Investing cash flow

69.12%-9.33M

-94.21%1.77M

-50.05%-9.26M

-153.09%-50.65M

-375.09%-44.76M

-911.00%-30.23M

193.87%30.5M

85.88%-6.17M

-5,928.01%-20.01M

394.80%16.27M

Financing cash flow

Cash flow from continuing financing activities

31,836.82%134.45M

-99.71%135K

-99.96%10K

18,694.63%72.71M

-102.04%-1K

53.09%421K

34,749.63%47.05M

3,069.18%25.24M

-100.94%-391K

-99.91%49K

Net issuance payments of debt

--137.26M

----

2,664.10%25M

--0

2,664.10%25M

-102.44%-975K

--0

Net common stock issuance

-215,000.00%-2.15M

----

--46.3M

---1K

--1K

----

--0

Proceeds from stock option exercised by employees

-52.62%199K

-82.02%135K

-97.25%10K

162.67%1.53M

--0

52.73%420K

456.30%751K

190.40%363K

170.37%584K

--49K

Net other financing activities

----

---125K

--0

----

---125K

----

Cash from discontinued financing activities

Financing cash flow

31,836.82%134.45M

-99.71%135K

-99.96%10K

18,694.63%72.71M

-102.04%-1K

53.09%421K

34,749.63%47.05M

3,069.18%25.24M

-100.94%-391K

-99.91%49K

Net cash flow

Beginning cash position

-14.33%84.2M

22.35%76.77M

-9.04%94.22M

-65.49%103.58M

36.94%152.18M

-33.74%98.29M

-66.44%62.75M

-65.49%103.58M

-45.89%300.15M

-66.10%111.13M

Current changes in cash

109.51%112.92M

-79.08%7.44M

57.26%-17.45M

95.24%-9.36M

-667.56%-57.97M

244.84%53.9M

192.08%35.54M

63.93%-40.83M

22.77%-196.57M

72.66%-7.55M

End cash Position

29.53%197.12M

-14.33%84.2M

22.35%76.77M

-9.04%94.22M

36.94%152.18M

-33.74%98.29M

-66.44%62.75M

-65.49%103.58M

Free cash flow

-114.61%-12.23M

113.18%5.54M

86.30%-8.21M

82.17%-31.41M

44.67%-13.21M

342.63%83.7M

14.48%-42.01M

12.80%-59.9M

40.49%-176.18M

72.56%-23.87M

Currency Unit

USD

Accounting Standards

US-GAAP

	(Q3)Sep 30, 2024	(Q2)Jun 30, 2024	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities	-114.58%-12.21M	113.18%5.54M	86.30%-8.21M	82.17%-31.41M	44.66%-13.21M	342.66%83.7M	14.48%-42.01M	12.79%-59.9M	40.41%-176.17M	72.53%-23.87M
Net income from continuing operations	-96.59%3.88M	114.45%6.88M	72.71%-10.71M	106.39%12.67M	72.80%-14.42M	418.08%113.93M	-17.52%-47.61M	43.15%-39.23M	43.02%-198.34M	43.22%-52.99M
Depreciation and amortization	-49.21%64K	-15.29%72K	-32.23%82K	-17.86%423K	-27.78%91K	-2.33%126K	-35.11%85K	-6.20%121K	4.25%515K	-5.26%126K
Other non cash items	31.39%1.04M	-10.75%1.2M	0.00%1.01M	0.25%4.45M	19.80%1.31M	-53.17%790K	93.08%1.34M	4.66%1.01M	85.28%4.44M	83.58%1.1M
Change In working capital	20.65%-31.83M	-30.44%-10.67M	78.58%-6.07M	-5,040.19%-84.66M	-147.33%-8.05M	-447.47%-40.11M	2.85%-8.18M	-871.66%-28.32M	86.52%-1.65M	294.33%17.01M
-Change in receivables	-47.09%-32.12M	-110.20%-18.63M	-61.07%-13.89M	-3,778.40%-51.09M	---11.77M	-24,913.64%-21.84M	-1,188.57%-8.86M	-1,870.64%-8.62M	200.00%1.39M	--0
-Change in inventory	-0.16%-2.54M	-29.82%-2.56M	-37.17%-36.93M	---36.94M	---5.51M	---2.54M	---1.97M	---26.92M	--0	--0
-Change in payables and accrued expense	154.25%11.67M	-3.44%8.96M	308.01%40.22M	101.74%192K	-84.39%2.56M	-253.69%-21.51M	182.95%9.28M	196.93%9.86M	-168.85%-11.01M	321.07%16.43M
-Change in other current assets	-2,339.18%-25.59M	115.69%1.05M	156.81%1.49M	-134.60%-2.83M	2,122.42%7.53M	-394.81%-1.05M	-616.83%-6.69M	-138.81%-2.62M	196.16%8.18M	127.06%339K
-Change in other current liabilities	-1,388.89%-1.39M	-87.27%14K	9,280.77%2.44M	645.45%300K	-80.21%56K	109.97%108K	-84.24%110K	-44.68%26K	99.70%-55K	102.49%283K
-Change in other working capital	170.28%18.14M	1,410.53%498K	1,684.21%602K	3,857.24%5.71M	-2,336.84%-926K	17,765.79%6.71M	0.00%-38K	0.00%-38K	0.00%-152K	0.00%-38K
Cash from discontinued investing activities
Operating cash flow	-114.58%-12.21M	113.18%5.54M	86.30%-8.21M	82.17%-31.41M	44.66%-13.21M	342.66%83.7M	14.48%-42.01M	12.79%-59.9M	40.41%-176.17M	72.53%-23.87M
Investing cash flow
Cash flow from continuing investing activities	69.12%-9.33M	-94.21%1.77M	-50.05%-9.26M	-153.09%-50.65M	-375.09%-44.76M	-911.00%-30.23M	193.87%30.5M	85.88%-6.17M	-5,928.01%-20.01M	394.80%16.27M
Net PPE purchase and sale	----	----	----	--0	--0	----	----	----	96.51%-14K	96.25%-3K
Net investment purchase and sale	69.20%-9.31M	-94.21%1.77M	-50.05%-9.26M	-153.27%-50.65M	-375.04%-44.76M	-912.36%-30.23M	193.87%30.5M	85.87%-6.17M	-29,084.06%-20M	383.14%16.27M
Cash from discontinued investing activities
Investing cash flow	69.12%-9.33M	-94.21%1.77M	-50.05%-9.26M	-153.09%-50.65M	-375.09%-44.76M	-911.00%-30.23M	193.87%30.5M	85.88%-6.17M	-5,928.01%-20.01M	394.80%16.27M
Financing cash flow
Cash flow from continuing financing activities	31,836.82%134.45M	-99.71%135K	-99.96%10K	18,694.63%72.71M	-102.04%-1K	53.09%421K	34,749.63%47.05M	3,069.18%25.24M	-100.94%-391K	-99.91%49K
Net issuance payments of debt	--137.26M	----	----	2,664.10%25M	--0	--0	--0	2,664.10%25M	-102.44%-975K	--0
Net common stock issuance	-215,000.00%-2.15M	----	----	--46.3M	---1K	--1K	----	----	--0	--0
Proceeds from stock option exercised by employees	-52.62%199K	-82.02%135K	-97.25%10K	162.67%1.53M	--0	52.73%420K	456.30%751K	190.40%363K	170.37%584K	--49K
Net other financing activities	----	----	----	---125K	--0	----	----	---125K	----	----
Cash from discontinued financing activities
Financing cash flow	31,836.82%134.45M	-99.71%135K	-99.96%10K	18,694.63%72.71M	-102.04%-1K	53.09%421K	34,749.63%47.05M	3,069.18%25.24M	-100.94%-391K	-99.91%49K
Net cash flow
Beginning cash position	-14.33%84.2M	22.35%76.77M	-9.04%94.22M	-65.49%103.58M	36.94%152.18M	-33.74%98.29M	-66.44%62.75M	-65.49%103.58M	-45.89%300.15M	-66.10%111.13M
Current changes in cash	109.51%112.92M	-79.08%7.44M	57.26%-17.45M	95.24%-9.36M	-667.56%-57.97M	244.84%53.9M	192.08%35.54M	63.93%-40.83M	22.77%-196.57M	72.66%-7.55M
End cash Position	29.53%197.12M	-14.33%84.2M	22.35%76.77M	-9.04%94.22M	-9.04%94.22M	36.94%152.18M	-33.74%98.29M	-66.44%62.75M	-65.49%103.58M	-65.49%103.58M
Free cash flow	-114.61%-12.23M	113.18%5.54M	86.30%-8.21M	82.17%-31.41M	44.67%-13.21M	342.63%83.7M	14.48%-42.01M	12.80%-59.9M	40.49%-176.18M	72.56%-23.87M
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall

No Data